Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Clinical trial NCT00497926 · TERMINATED
Trial details
- NCT number
- NCT00497926
- Sponsor
- Talaris Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2023-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.